ALLMedicine™ Withdrawal Syndromes Center
Research & Reviews 56 results
Molecular Pharmacology; Senese NB, Rasenick MM
May 20th, 2021 - Termination of antidepressant therapy often has negative consequences. While symptoms of antidepressant withdrawal are widely recognized, the molecular processes that underlie them are not well characterized. We show that certain aspects of Gαs si...
Neuroscience and Biobehavioral Reviews; O'Sullivan SJ, Schwaber JS
Mar 1st, 2021 - Alcohol and opioids are two major contributors to so-called deaths of despair. Though the effects of these substances on mammalian systems are distinct, commonalities in their withdrawal syndromes suggest a shared pathophysiology. For example, bot...
Journal of Psychopharmacology (Oxford, England); Gallo AT, Hulse G
Jan 11th, 2021 - The estimated annual prevalence of drug use disorders is as high as 3%, underpinning the need to continually develop more effective treatments. Central nervous system dysregulation, contributing to acute and post-withdrawal syndromes, has traditio...
A&A Practice; Boncyk CS, Brennan KA et. al.
Nov 13th, 2020 - Polytrauma patients are at high risk for neurologic complications as a result of the primary mechanism of their trauma and/or delirium caused by subsequent pain, sedatives and analgesic exposure, sleep disturbances, infections, metabolic derangeme...
Expert Opinion on Pharmacotherapy; Glahn A, Proskynitopoulos PJ et. al.
Apr 13th, 2020 - Alcohol withdrawal syndrome is a common and life-threatening condition in patients suffering from alcohol use disorder. Treatment of this syndrome is challenging, especially in patients that are critically ill, either because of withdrawal symptom...
Drugs 1 results see all →
Clinicaltrials.gov 1 results
Jan 11th, 2017 - Although there are clearly identifiable withdrawal syndromes following cessation of a number of abused drugs such as alcohol and heroin, it is unclear whether a withdrawal syndrome follows the cessation of crack cocaine. A laboratory model of with...
News 1 results
Sep 12th, 2011 - Battery problems with two of Medtronic's SynchroMed II implantable infusion pumps have forced the company to recall them, according to the FDA, although the recall only affects products not yet implanted. The company has determined that the batter...